[Federal Register Volume 61, Number 52 (Friday, March 15, 1996)]
[Notices]
[Pages 10772-10773]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6281]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health; Notice of Meeting

    Notice is hereby given of the third meeting of the Task Force on 
Genetic Testing of the National Institutes of Health--Department of 
Energy Joint Working Group on the Ethical, Legal, and Social 
Implications of Human Genome Research (ELSI Working Group) on Monday, 
April 29, 1996, 8:30 a.m. to recess; Tuesday, April 30, 1996, 8:30 a.m. 
to adjournment, at the Clarion Hotel at Mount Vernon Square, 612 
Cathedral Street, Baltimore, Maryland, (410) 727-7101.
    Contact Person: Joshua H. Brown, J.D., Genetics and Public Policy 
Studies, The Johns Hopkins Medical Institutions, 550 North Broadway, 
Suite 511, Baltimore, Maryland 21205, (410) 955-7894. An agenda for the 
meeting may be obtained from Mr. Brown.
    The Task Force on Genetic Testing has developed a set of interim 
principles in three areas: scientific validation of new tests; 
laboratory quality; and, education, counseling, and delivery. These 
interim principles are being made public to give interested parties an 
opportunity to comment before the principles are finalized. A copy of 
the principles is available from Mr. Brown upon request.
    Public Comment: Individuals or representatives of organizations 
wishing to make an oral presentation, of no more than 10 minutes, to 
the Task Force on Monday, April 29, between 2:00 p.m. and 4:30 p.m., 
should submit their name, affiliation, address, telephone number, and 
summary of their remarks to Mr. Brown at the above address by April 18. 
Written comments will be accepted up to May 31. Written comments 
received by April 18 will be considered by the Task Force at the April 
29 meeting. All comments, whether oral or written, will be given full 
consideration by the Task Force on Genetic Testing.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Mr. Brown in advance of the meeting.


[[Page 10773]]

    Dated: March 12, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-6281 Filed 3-14-96; 8:45 am]
BILLING CODE 4140-01-M